echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > When trying to conceive, this oral hypoglycemic agent is replaced with insulin

    When trying to conceive, this oral hypoglycemic agent is replaced with insulin

    • Last Update: 2023-01-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    For medical professionals only



    Learn a hot search medicine every day


     

    Gliclazide is suitable for mild and moderate non-insulin-dependent diabetes mellitus that is not satisfactory with diet control efficacy, and the patient's islet β cells have a certain insulin secretion function and no serious complications
    .
    It is mainly used for mild and medium-sized diabetes mellitus
    that is ineffective with diet control alone and has no tendency to ketosis in adulthood.

    It can also improve fundus lesions and metabolic and vascular function disorders in diabetics
    .
    It can be combined with biguanide oral hypoglycemic agents in patients who cannot be controlled alone, and in combination with insulin for the treatment of insulin-dependent diabetes, which can reduce the amount of
    insulin.

    So, can it also be used during pregnancy and lactation?







    Pregnancy preparation: clinical data on the use of gliclazide in pregnant women with insulin
    deficiency by replacing oral drugs, Data on other sulfonylureas are scarce
    .
    In animals, gliclazide is not teratogenic
    .

    To reduce the risk of congenital malformations in uncontrolled diabetes, diabetes
    must be controlled before pregnancy.
    Oral hypoglycemic agents during pregnancy are not suitable, so insulin is used as continued treatment
    for diabetes.
    It is recommended to switch oral hypoglycemic drugs to insulin therapy from the time when pregnancy is planned or when pregnancy is discovered
    .








    Can it be used during lactation?
    Data
    on the entry of gliclazide and its metabolites into breast milk are lacking.

    Given the risk of hypoglycemia in newborns, the use of gliclazide
    is contraindicated in lactating women.








    Where can I find more information on pregnancy/lactation medication?
    What drugs should not be touched during pregnancy? What medications are secreted through breast milk?
    Scan the code to download the clinical decision-making app

    in 3 steps Rapid access to safe medication information during pregnancy/lactation References:[1] Drug information
    : gliclazide sustained-release capsules
    , Hangzhou Guoguang Pharmaceutical Co.
    , Ltd.
    , Sinopharm H20070261; 2012/11/13.

    ▼▼▼Click to read the original article to download the App

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.